KLRS
Kalaris Therapeutics
KLRS
KLRS
85 hedge funds and large institutions have $192M invested in Kalaris Therapeutics in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
34% less capital invested
Capital invested by funds: $294M → $192M (-$101M)
Holders
85
Holding in Top 10
–
Calls
$110K
Puts
$81K
Top Buyers
| 1 | +$1.81M | |
| 2 | +$766K | |
| 3 | +$743K | |
| 4 |
Renaissance Technologies
New York
|
+$632K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$399K |
Top Sellers
| 1 | -$1.63M | |
| 2 | -$1.23M | |
| 3 | -$908K | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$883K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$263K |